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ABSTRACT: Rosacea is a common chronic inflammatory disorder showing a wide range of clinical
features such as telangiectasia, erythema, papules, and pustules primarily involving the central part
of face (forehead, cheeks and nose) although extra facial manifestation have been described. We
describe a case of rosacea with predominant scalp involvement successfully treated with a 8-week-
course of doxycycline 40 mg once a day and probiotic therapy twice a day (Bifidobacterium breve
BR03, Lactobacillus salivarius LS01 13 109 UFC/dose).
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Introduction
Rosacea is a common chronic inflammatory dis-
order showing a wide range of clinical features
such as telangiectasia, erythema, papules, and
pustules primarily involving the central part of
face (forehead, cheeks, and nose) although extra
facial manifestation have been described; in par-
ticular rosacea affecting the bald scalp is unusual
with few reports in the literature. Facial rosacea
is most commonly observed in young women
aged between 30 and 40; otherwise scalp rosacea
(SR) is more frequent in aged bald man where
the diagnosis is more difficult because of its
atypical pattern. Scalp involvement is character-
ized by pustules on erythematous background,
and is a diagnostic challenge due to its atypical
clinical pattern. Furthermore, two rare variants
of rosacea have been reported: granulomatous
variant, which can manifest with erythematous
and monomorphic papules or nodules with peri-
orificial location; and rosacea fulminans, charac-
terized by the sudden eruption of cystic nodules,
papules and pustules over the chin, cheeks, and
forehead.
The etiopathogenesis of extrafacial rosacea is
still unclear but several factors have been impli-
cated such as disorders of vascular reactivity,
genetic predisposition, weather conditions, and
immune response against microorganisms such as
Demodex folliculorum and Helicobacter pylori (1).
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The histopathology of rosacea is not very useful
because it depends on the disease stage.
Rosacea can be a challenge to diagnose, and
many other diseases have to be considered in
the differential diagnosis. Among this seborrheic
dermatitis predominantly involves the eyebrows,
periauricular, paranasal, and glabellar region;
acne can be excluded in the absence of comedo
formation; keratosis pilaris rubra presents with
marked erythema and keratotic follicular papules
affecting the cheeks and the proximal arms; lupus
erythematous is characterized by the presence of
erythema over the cheeks and nasal bridge (malar
rash); in particular in differential diagnosis of SR
it is important to consider scalp pustolosis (follic-
ulitis decalvans, dissecting cellulitis, eosinophilic
folliculitis, acne miliaris necrotica) (2).
Case report
We describe a case of rosacea with predomi-
nant scalp involvement. A 37-year-old man was
observed in our dermatology department with
a 2-year-history of an intermittent scalp ery-
thema and burning sensation. The erythema
was thought to be worsened by stress. There
was no history of systemic or topical steroid
application to the face or scalp. Patient denied
past medical history and drugs intake. Based on
the clinical features, a diagnosis of rosacea with
predominant scalp involvement was made.
On clinical examination, he had widespread
erythematous papules and pustules over his fore-
head and extending to involve the entire vertex
of his scalp, which was bald. There was extensive
crusting especially over the scalp. To a lesser
extent, there was involvement of his cheeks and
nose with smaller erythematous papules and
pustules (Fig. 1a). Moreover blepharitis and con-
junctivitis were present, the most common ocu-
lar manifestations in rosacea (Fig. 1e) (3,4).
The dermoscopy revealed the characteri-
stic scalp pattern: vascular polygons, as already
reported by Lallas et al. (5), follicular openings,
some of which occupied by vellus hair, hyperkera-
tosis, and plugging of follicular ostia (Fig. 1c) (6).
A cutaneous swab was made to exclude bacte-
rial or fungal infections, with negative result. He
was treated with an 8-week-course of doxycy-
cline 40 mg once a day and probiotic therapy
twice a day (Bifidobacterium breve BR03, Lacto-
bacillus salivarius LS01 1 3 109 UFC/dose). After
8 weeks the patient came back to our depart-
ment with a significant improvement of cutane-
ous and ocular manifestations; in particular
crusting and pustules had completely disap-
peared leaving only a mild erythema (Figs. 1b,f);
FIG. 1. (a, T0): erythematous papules and pustules that involve the entire vertex of scalp; (b, T1): crusting and pustules
had completely disappeared; (c, T0) dermoscopy: vascular polygons, follicular openings, some of which occupied by vellus
hair, hyperkeratosis and plugging of follicular ostia; (d, T1) dermoscopy: polygonal vessels were absent; (e, T0): blepharitis
and conjunctivitis; (f, T1): resolution of ocular manifestations.
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the polygonal vessels observed on dermoscopy
were absent (Fig. 1d). The patient was suggested
to stop the treatment with doxycycline and to
continue with the use of probiotic.
Discussion
SR is a rare entity with only few reports in litera-
ture but has to be considered in the differential
diagnosis of the folliculitis of the scalp; it is more
frequent in man and is a diagnostic challenge
due to its atypical clinical pattern. Generally, SR
presents with papules and pustules on the scalp
on an erythematous background and can be
treated with topical therapies like metronidazole,
azelaic acid, ivermectin along with systemic thera-
pies such as oral tetracycline (doxycycline or min-
ocycline 100 mg once daily for 3 weeks with
gradual tapering to the least effective dose over
several weeks or months), metronidazole, low dose
isotretinoin (0.1–0.2 mg/kg/day) in severe cases
and other oral antibiotics such as azithromycin or
erythromycin can be considered. Recently, has also
been approved the use of low dose doxycycline
(40 mg once a day). In some selected cases, when
telangiectasia and rhinophyma occur laser and
surgery can be used (7–10).
In the case we reported, the patient presented
with papules and pustules located on face and
bald scalp along with blepharitis and conjuncti-
vitis. Excluded other fungal or bacterial infection
and common inflammatory skin diseases the
diagnosis of rosacea was made.
The treatment was based on low-dose doxycy-
cline and probiotic therapy.
Doxycycline, when used at the dosage of
40 mg daily, only shows an anti-inflammatory
activity, reducing the onset of antibiotic resistan-
ces often observed with the use of doxycycline
100 mg once a day. In literature is reported the
potential role of intestinal dysbiosis in the rosa-
cea’s pathogenesis. This condition is common to
other inflammatory skin diseases, such as atopic
dermatitis and psoriasis and, for this reason, we
administered probiotics to our patient (10,11).
In conclusion, we reported a case of rosacea
with scalp involvement successfully treated with
association of low-dose doxycycline and probiot-
ics. The therapy was effective, well tolerated,
with no side effects.
After 6 months of follow-up, our patient didn’t
show relapse or flare-up of disease.
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